These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 26160144

  • 1. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I, Al-Otaibi B, AlHindas H, Okarvi SM.
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA, Al-Otaibi B, Al-Hokbani N, Okarvi SM.
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [Abstract] [Full Text] [Related]

  • 3. Novel synthesis and preclinical evaluation of folic acid derivatives labeled with (18)F-[FDG] for PET imaging of folate receptor-positive tumors.
    Al Jammaz I, Al-Otaibi B, Amer S, Al-Hokbany N, Okarvi S.
    Nucl Med Biol; 2012 Aug; 39(6):864-70. PubMed ID: 22445744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer.
    Bartholomä MD, He H, Pacak CA, Dunning P, Fahey FH, McGowan FX, Cowan DB, Treves ST, Packard AB.
    Nucl Med Biol; 2013 Nov; 40(8):1043-8. PubMed ID: 24011396
    [Abstract] [Full Text] [Related]

  • 8. Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).
    Bartholomä MD, Gottumukkala V, Zhang S, Baker A, Dunning P, Fahey FH, Treves ST, Packard AB.
    J Med Chem; 2012 Dec 27; 55(24):11004-12. PubMed ID: 23210516
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
    Mou T, Zhao Z, You L, Wang Q, Fang W, Lu J, Peng C, Zhang X.
    J Labelled Comp Radiopharm; 2015 Jun 30; 58(8):349-54. PubMed ID: 26094722
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
    Furumoto S, Shinbo R, Iwata R, Ishikawa Y, Yanai K, Yoshioka T, Fukuda H.
    J Nucl Med; 2013 Aug 30; 54(8):1354-61. PubMed ID: 23843565
    [Abstract] [Full Text] [Related]

  • 11. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N.
    Nucl Med Biol; 2011 Oct 30; 38(7):953-9. PubMed ID: 21982567
    [Abstract] [Full Text] [Related]

  • 12. Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent.
    Gottumukkala V, Heinrich TK, Baker A, Dunning P, Fahey FH, Treves ST, Packard AB.
    Nucl Med Biol; 2010 Apr 30; 37(3):365-70. PubMed ID: 20346876
    [Abstract] [Full Text] [Related]

  • 13. (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.
    Zhang Y, Dasilva JN, Hadizad T, Thorn S, Kuraitis D, Renaud JM, Ahmadi A, Kordos M, Dekemp RA, Beanlands RS, Suuronen EJ, Ruel M.
    Cell Transplant; 2012 Apr 30; 21(9):1821-35. PubMed ID: 22469629
    [Abstract] [Full Text] [Related]

  • 14. Highly efficient one-pot labeling of new phosphonium cations with fluorine-18 as potential PET agents for myocardial perfusion imaging.
    Zhao Z, Yu Q, Mou T, Liu C, Yang W, Fang W, Peng C, Lu J, Liu Y, Zhang X.
    Mol Pharm; 2014 Nov 03; 11(11):3823-31. PubMed ID: 24852080
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging.
    Kim DY, Kim HJ, Yu KH, Min JJ.
    Nucl Med Biol; 2012 Oct 03; 39(7):1093-8. PubMed ID: 22575270
    [Abstract] [Full Text] [Related]

  • 16. Preparation and biodistribution of [18F]FP2OP as myocardial perfusion imaging agent for positron emission tomography.
    Mou T, Jing H, Yang W, Fang W, Peng C, Guo F, Zhang X, Pang Y, Ma Y.
    Bioorg Med Chem; 2010 Feb 03; 18(3):1312-20. PubMed ID: 20056551
    [Abstract] [Full Text] [Related]

  • 17. Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging.
    Tang C, Nie D, Tang G, Gao S, Liu S, Wen F, Tang X.
    Nucl Med Biol; 2017 Jul 03; 50():39-46. PubMed ID: 28456080
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and Evaluation of (18)F-labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese mini-swine.
    Mou T, Zhao Z, You L, Li Y, Wang Q, Fang W, Lu J, Peng C, Zhang X.
    Sci Rep; 2016 Sep 20; 6():33450. PubMed ID: 27646847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.